In-Med Prognostics

We are a globally distributed health tech startup incubated in the GE Healthcare Edison Accelerator. We are the first in the world to integrate data from multiple modalities for neurological health and provide ethnicity specific decision support insights for physicians and clinical researchers.

Our proprietary software, Neuroshield™ integrates images, signal and text to produce automated, quantified reports to support the physician’s clinical impression for various neurological disorders. And it provides a seamless, end-to-end cloud-based image analysis platform for clinical and research use. Leveraging state-of-the-art data analytics and deep learning methodologies, we are developing a biomarker algorithm for various neurological disorders starting with epilepsy, dementia, Alzheimer’s Disease and Parkinson’s disease.

In-Med was founded by Rajesh Purushottam, Dr. Latha Poonamallee & Dr. Al Curran.

Company’s Keywords:

neurology, data analytics, radiology, neuroscience, deep learning, segmentation, software, social innovation, predictive analytics, volumetric analysis, brain volumetry